Evaluating the Optimal Volume Voided for Passage of a Backfill-Assisted Voiding Trial Following Urogynecologic Surgery
Status
Conditions
Treatments
Details and patient eligibility
About
Urinary retention can lead to bladder over-distention, ischemia, and long-term voiding dysfunction, and early identification of urinary retention can help prevent these adverse events
Full description
Postoperative voiding trials (VT) can identify as well as prevent postoperative urinary retention. Voiding trial protocols vary by provider and healthcare facilities/institutions as there is no consensus on how to prevent postoperative urinary retention optimally. Identification of an optimal VT could not only help decrease adverse events associated with urinary retention but also decrease postoperative catheter-associated urinary tract infection (CAUTI) rates, unplanned hospital or clinic visits, and decrease patient discomfort while increasing patient satisfaction.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Nonpregnant women >18yo undergoing pelvic organ prolapse or urinary incontinence surgery
Exclusion criteria
- Patients undergoing fistula repair or sacral neuromodulation
- Voiding dysfunction preoperatively that requires intermittent self-catheterization
- Intraoperative bladder injury
- Pregnancy
- Preoperative UTI (culture proven within 7 days prior to surgery)
Trial design
Primary purpose
Allocation
Interventional model
Masking
100 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Bryar Thompson, DO
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal